Phase II study of a BD-HDM regimen for multiple myeloma patients
Latest Information Update: 29 Apr 2019
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Melphalan
- Indications Multiple myeloma
- Focus Adverse reactions
- Acronyms Bomb-MM01
- 25 Apr 2019 Status changed from recruiting to completed.
- 03 Jan 2014 New trial record